China receiving check
Mainland China procurement requires review of the authorised recipient, product and import route.
Preparing a medicine enquiry from India for China? Start with the active ingredient, strength, dosage form, manufacturer and pack. Review the exact product, receiving-party permissions and documentation needs, then identify the receiving person or organisation and intended use before discussing available documents and shipment handling.
Mainland China procurement requires review of the authorised recipient, product and import route.
Branded and generic medicines across relevant therapeutic categories, with product information and quotation support.
Invoice, packing information, manufacturer details, COA or COO support where applicable and available.
Start with your buyer type and the exact medicine. The relevant receiving route must be checked for each request.
Personal-use provisions are separate from commercial import. Ask your treating clinician and the relevant Chinese authority about the exact medicine and intended route before ordering.
Mainland China procurement requires review of the authorised recipient, product and import route. Urgent clinical imports for a medical institution require the applicable approvals and designated use.
Include the product, strength, dosage form, pack size, quantity, destination and intended use. Available product documents and handling requirements can then be discussed.
Official destination guidance
For mainland China, establish the receiving organisation and product permissions first. An urgent clinical-use pathway is not a general retail-import permission. Official import guidance.
Share the receiving organisation or buyer, postal destination and intended use. Confirm the applicable receiving route before requesting shipment coordination.
Buyers can also review support pages for bulk enquiries, hospital supply, cold-chain medicines, specialty sourcing and pharmaceutical documentation.
Buyers can browse category-specific enquiry pages for relevant products, strengths and pack sizes.
Individuals, importers, pharmacies, clinics, hospitals and procurement teams may send product enquiries for review. Acceptance of an enquiry does not confirm medicine availability, permission to supply or import eligibility.
Personal-use provisions are separate from commercial import. Ask your treating clinician and the relevant Chinese authority about the exact medicine and intended route before ordering.
Mainland China procurement requires review of the authorised recipient, product and import route. Urgent clinical imports for a medical institution require the applicable approvals and designated use.
State the medicine or active ingredient, strength, dosage form, pack size, quantity, destination and buyer type. The team can then discuss product information and available documentation. Do not send medical histories or identity documents in an initial general enquiry.
No. Product availability and price do not establish permission to supply or import. The applicable receiving route and product requirements must be confirmed before shipment is arranged.